Willow Biosciences (TSE:WLLW) Sets New 1-Year Low – Should You Sell?

Willow Biosciences Inc. (TSE:WLLWGet Free Report)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.03 and last traded at C$0.03, with a volume of 201000 shares. The stock had previously closed at C$0.03.

Willow Biosciences Trading Up 25.0 %

The company has a debt-to-equity ratio of 131.61, a current ratio of 0.70 and a quick ratio of 19.71. The business’s 50-day simple moving average is C$0.06 and its two-hundred day simple moving average is C$0.08. The stock has a market capitalization of C$3.61 million, a price-to-earnings ratio of -0.42 and a beta of 1.13.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

Further Reading

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.